Pemeriksaan Awal Golongan Darah dalam Sarana Pencegahan Terjadinya Inkompatibilitas ABO pada Perempuan Usia Produktif di Kelurahan Krendang, Jakarta Barat

Christian Wijaya; Alexander Halim Santoso; Tizander Mayvians; Edwin Destra; Fransiska Iriani Rosmala Dewi

doi:10.59603/jpmnt.v3i1.668

Authors

Christian Wijaya Universitas Tarumanagara
Alexander Halim Santoso Universitas Tarumanagara
Tizander Mayvians Universitas Tarumanagara
Edwin Destra Universitas Tarumanagara
Fransiska Iriani Rosmala Dewi Universitas Tarumanagara

DOI:

https://doi.org/10.59603/jpmnt.v3i1.668

Keywords:

health education, ABO incompatibility, prevention, blood type screening, women of reproductive age

Abstract

ABO incompatibility is a medical condition that occurs when the mother’s blood type differs from the fetus she is carrying, potentially triggering immunological reactions harmful to both the mother and the fetus. This condition poses a significant risk in pregnancy and blood transfusions. Therefore, early blood type screening is essential for women of reproductive age as a preventive measure against ABO incompatibility. The education and blood type screening program was implemented using the Plan-Do-Check-Act (PDCA) approach, involving education, blood type screening, and evaluation. Through early detection and health education, women of reproductive age can better understand the risks of ABO incompatibility and take appropriate preventive actions. Proper education and regular screening can reduce pregnancy complications caused by ABO incompatibility and increase awareness among women of reproductive age about the importance of maintaining reproductive health. Early blood type screening plays a crucial role in preventing ABO incompatibility, thereby minimizing the risk of pregnancy complications in women of reproductive age.

References

Alshehri, A. A., & Jackson, D. E. (2021). Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis. Transfusion Medicine Reviews, 35(2), 85–94. https://doi.org/10.1016/j.tmrv.2021.02.001

Christensen, R. D., Baer, V. L., MacQueen, B. C., O’Brien, E., & Ilstrup, S. J. (2018). ABO Hemolytic Disease of the Fetus and Newborn: Thirteen Years of Data After Implementing a Universal Bilirubin Screening and Management Program. Journal of Perinatology, 38(5), 517–525. https://doi.org/10.1038/s41372-018-0048-4

Dana, M., & Fibach, E. (2018). Elimination of ABO Blood Group Incompatible Fetal Red Blood Cells in the Maternal Circulation: Relevance to the Diagnosis of Fetal-Maternal Hemorrhage. Neonatology, 114(4), 303–306. https://doi.org/10.1159/000490371

Das, S. (2019). Hemolytic Disease of the Fetus and Newborn. https://doi.org/10.5772/intechopen.85316

Galliano, D. (2017). ABO Blood Group Incompatibility and Infertility: Still an Open Debate. Fertility and Sterility, 107(3), 579. https://doi.org/10.1016/j.fertnstert.2016.12.010

Liu, X., Dong, Y., Qin, Y., Xue, C., & Lyu, W. (2023). Clinical Value of Combined Predictors of RET%, Γ-Gt, LDH in the ABO Neonatal Hemolytic Disease. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1265739

Mishra, D., Varghese, S., Prakash, S., Mukherjee, S., & Sahu, A. (2023). Hemolytic Disease of the Fetus and Newborn Due to Minor Blood Group Alloimmunization in a Mother of Sickle Cell Disease With Multiple Alloantibodies. Asian Journal of Transfusion Science, 17(2), 291. https://doi.org/10.4103/ajts.ajts_161_22

Mohan, D. R., Lu, H., McClary, J., Marasch, J., Nock, M., & Ryan, R. M. (2023). Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants With Hemolytic Disease. Children, 10(3), 496. https://doi.org/10.3390/children10030496

Myle, A. K., & Al-Khattabi, G. H. (2021). Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects. Pediatric Health Medicine and Therapeutics, Volume 12, 491–498. https://doi.org/10.2147/phmt.s327032

Neamţu, S. D., Novac, M. B., Neamţu, A. V., Stanca, I. D., Boldeanu, M. V., Gluhovschi, A., Stanca, L., Dijmărescu, A. L., Manolea, M. M., Trăistaru, M. R., Mateescu, G. O., & Siminel, M. A. (2022). Fetal–maternal Incompatibility in the Rh System. Rh Isoimmunization Associated With Hereditary Spherocytosis: Case Presentation and Review of the Literature. Romanian Journal of Morphology and Embryology, 63(1), 229–235. https://doi.org/10.47162/rjme.63.1.26

Nyakio, O., Kibukila, F., Suvvari, T. K., Bhattacharjee, P., Akilimali, A., & Mukwege, D. (2024). Prevalence of Fetomaternal Rhesus Incompatibility at the Tertiary Care Hospital; A Cross-Sectional Study. Annals of Medicine and Surgery. https://doi.org/10.1097/ms9.0000000000001846

Nyarko, S. H., Boateng, E. N. K., Dickson, K. S., Adzrago, D., Addo, I. Y., Acquah, E., & Ayebeng, C. (2023). Geospatial Disparities and Predictors of Anaemia Among Pregnant Women in Sub-Saharan Africa. BMC Pregnancy and Childbirth, 23(1). https://doi.org/10.1186/s12884-023-06008-3

Obukhova, P., Качанов, А. В., Позднякова, Н. А., & Ziganshina, M. M. (2021). AB0-incompatibility of Mother and Fetus: The Role of Anti-Glycan Alloantibodies in the Hemolytic Disease of Newborns. Medical Immunology (Russia), 23(1), 17–34. https://doi.org/10.15789/1563-0625-aom-1977

Ozen, M., Yılmaz, S., Özkan, T., Ozer, Y., Pekel, A. A., Sunguroğlu, A., Gürman, G., & Arslan, Ö. (2018). Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study. Turkish Journal of Hematology, 35(1), 54–60. https://doi.org/10.4274/tjh.2016.0504

Simmons, D. P., & Savage, W. (2015). Hemolysis From ABO Incompatibility. Hematology/Oncology Clinics of North America, 29(3), 429–443. https://doi.org/10.1016/j.hoc.2015.01.003

Wan Mohd Hasni, S. A., Ahmad, N. H., Ganeshan, M., Yong, S. L., Tan, P. P., Wahab, R. A., Musa, R. H., Muniandi, G., Nakulan, A., & Hassan, A. (2024). A Challenging Case of Hemolytic Disease of the Fetus and Newborn (HDFN) Due to Anti-Ku in a K₀ (Kell_null) Mother. Immunohematology, 40(3), 122–127. https://doi.org/10.2478/immunohematology-2024-016

Wu, S., Wu, Y., Guo, G., Xie, R., & Wu, Y. (2024). Comparison of the Detection Rate and Specificity of Irregular Red Blood Cell Antibodies Between First-Time Pregnant Women and Women With a History of Multiple Pregnancies Among 18,010 Chinese Women. Journal of Pregnancy, 2024, 1–6. https://doi.org/10.1155/2024/5539776